Christopher Patusky - Nov 16, 2022 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
Director
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Stock symbol
UTHR
Transactions as of
Nov 16, 2022
Transactions value $
-$285,791
Form type
4
Date filed
11/18/2022, 03:30 PM
Previous filing
Aug 18, 2022
Next filing
Jan 4, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise $132K +1.5K +89.29% $88.03 3.18K Nov 16, 2022 Direct F1
transaction UTHR Common Stock Disposed to Issuer -$392K -1.5K -47.17% $261.05 1.68K Nov 16, 2022 Direct F1
transaction UTHR Common Stock Sale -$26.3K -100 -8.33% $262.61 1.1K Nov 17, 2022 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Share Tracking Award Options Exercise $0 -1.5K -13.04% $0.00 10K Nov 16, 2022 Common Stock 1.5K $88.03 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.
F2 Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.